Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.


Sales per Businesses
20152016Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies26.75100%33.46100% +25.08%
Sales per Regions
20152016Delta
CAD (in Million)%CAD (in Million)%
Europe13.5350.6%14.4843.3% +7.08%
Rest of World13.2349.4%18.9856.7% +43.5%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Jennifer Archibald-2006Chief Financial Officer
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD592015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Hugues Sachot-2013Senior Vice President-Sales & Commercial
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 31,900,185 31,301,265 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 5,078,393 15.9%
Putnam Investment Management LLC 3,508,988 11.0%
Stonepine Capital Management LLC 3,158,816 9.91%
Clough Capital Partners LP 2,044,653 6.41%
Tamarack Advisers LP 1,825,000 5.73%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 607,452 1.91%
AlphaOne Investment Services LLC 550,965 1.73%
Sabby Capital LLC 437,720 1.37%
Renaissance Technologies LLC 215,013 0.67%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP3.54%98
BIOGEN INC4.89%59 195
CSL LIMITED22.30%42 634
ALEXION PHARMACEUTICAL..-3.12%26 623
BIOMARIN PHARMACEUTICA..7.56%15 402
GRIFOLS SA19.52%15 183
CHONGQING ZHIFEI BIOLO..--.--%4 267
3SBIO INC26.71%3 129
JIANGXI BOYA BIO-PHARM..--.--%2 510
ABCAM PLC7.04%2 073
PROMETIC LIFE SCIENCES..-3.51%1 098
HUGEL INC--.--%1 069
BIOTEST AG21.82%826
PHARMA MAR SA9.96%716
ANIKA THERAPEUTICS INC-13.07%623
SYROS PHARMACEUTICALS ..23.36%351
CHEMOCENTRYX INC-2.57%347
SYNDAX PHARMACEUTICALS..91.35%250
KADMON HOLDINGS INC-32.15%188
MEDIWOUND LTD43.04%144
ALIMERA SCIENCES INC31.48%92
Sector Biopharmaceuticals
Cardiome Pharma Corp : Connections
Zalicus Pharmaceuticals Ltd.
Michael Smith Foundation for Health Research
Blackthorn Therapeutics, Inc.
Pamlico BioPharma, Inc.
Trevi Therapeutics, Inc.
Richardson Capital Ltd.
Kyowa Kirin International Plc
Premier's Technology Council
Synereca Pharmaceuticals, Inc.
British Columbia Lottery Corp.
Quartet Medicine, Inc.
The 2010 Games Operating Trust
Brighton Biotech, Inc.
Pacific Autism Family Centre Foundation
Vancouver Symphony Orchestra
enGene, Inc.
MedGenesis Therapeutix, Inc.
The Vancouver Symphony Foundation
Vida Pharmaceuticals Pvt Ltd.
Advanced Applied Physics Solutions, Inc.
Kearny Venture Partners
Virginia Center For Translational & Regulatory Sciences
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2017 People , Fundamentals and Ownership